IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

IRBM, has established a comprehensive Functional Genomics Platform to support genetic target identification and validation, ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its ...

A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9, a technology that allows genes to be manipulated inside the body. The two companies claim AGN ...

Cancer continues to be a formidable challenge globally, with traditional drug discovery methods focusing on cytotoxic agents and targeted therapies altering the landscape of cancer prognosis and ...

If we cut or limit funding for curiosity-driven research, we risk shutting down the pipeline of future innovation,” writes ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

The global human organoid market has garnered considerable attention in recent years, emerging as one of the most promising ...

Plex Research, a biotechnology company using autonomous artificial intelligence (AI) to aid in drug discovery, today announced that it is partnering with Ginkgo Datapoints, a service of Ginkgo ...